Allianz Asset Management GmbH Sells 412,873 Shares of Align Technology, Inc. $ALGN

Allianz Asset Management GmbH cut its stake in shares of Align Technology, Inc. (NASDAQ:ALGN) by 80.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 97,837 shares of the medical equipment provider’s stock after selling 412,873 shares during the period. Allianz Asset Management GmbH’s holdings in Align Technology were worth $12,251,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of ALGN. Ninety One UK Ltd increased its stake in Align Technology by 18.3% in the 3rd quarter. Ninety One UK Ltd now owns 2,267,192 shares of the medical equipment provider’s stock valued at $283,898,000 after buying an additional 350,883 shares during the last quarter. Federated Hermes Inc. increased its position in shares of Align Technology by 31.0% during the 2nd quarter. Federated Hermes Inc. now owns 926,733 shares of the medical equipment provider’s stock valued at $175,458,000 after purchasing an additional 219,219 shares during the last quarter. Disciplined Growth Investors Inc. MN increased its position in shares of Align Technology by 0.9% during the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 844,987 shares of the medical equipment provider’s stock valued at $159,981,000 after purchasing an additional 7,754 shares during the last quarter. Norges Bank bought a new stake in shares of Align Technology during the 2nd quarter worth $155,297,000. Finally, Bank of America Corp DE boosted its holdings in shares of Align Technology by 60.7% in the 2nd quarter. Bank of America Corp DE now owns 786,637 shares of the medical equipment provider’s stock worth $148,934,000 after buying an additional 297,117 shares during the last quarter. 88.43% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Align Technology

Here are the key news stories impacting Align Technology this week:

Please show the positive items first, then the neutral items, and finally the negative items.
• Positive Sentiment: Q4 results beat consensus — EPS $3.29 vs $2.99 est and revenue $1.05B vs $1.03B; management highlighted strong demand for clear aligners which drove record Invisalign volumes, a primary driver of the stock rally. Align Technology beats fourth-quarter results estimates on dental products demand
• Positive Sentiment: Major analyst price-target increases from Leerink (to $225) and Mizuho (to $215) boost upside perception and reflect analyst model upgrades after the quarter. Leerink Partners adjusts Align Technology PT to $225 Mizuho adjusts price target on Align Technology to $215
• Positive Sentiment: CEO Joseph Hogan framed the macro/demand backdrop as more stable and cited rising teen and international demand — supportive commentary for forward growth expectations. The markets are ‘more stable than what we experienced in the past,’ says Align Technology CEO
• Neutral Sentiment: Company set a modest 2026 revenue growth target of 3%–4% and issued Q1 revenue guidance roughly in line with Street estimates — suggests steady but not accelerating top-line growth. Align Technology outlines 3-percent–4-percent revenue growth target for 2026
• Neutral Sentiment: Analyst ratings are mixed: Jefferies raised its PT to $185 but kept a “hold,” and Morgan Stanley moved its PT to $169 with an “equal weight” stance — shows divergence in conviction despite upgrades. Jefferies co adjusts Align Technology price target to $185 Morgan Stanley raises price target
• Negative Sentiment: Margins declined in the quarter — gross and operating margins fell despite the volume beat, a profitability headwind that could limit multiple expansion if trends persist. ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down

Align Technology Stock Up 6.8%

NASDAQ ALGN opened at $187.60 on Monday. The firm has a market cap of $13.46 billion, a P/E ratio of 33.14, a price-to-earnings-growth ratio of 2.10 and a beta of 1.84. The company’s 50 day moving average is $163.26 and its 200-day moving average is $148.06. Align Technology, Inc. has a 12-month low of $122.00 and a 12-month high of $224.18.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.99 by $0.30. The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.03 billion. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.44 EPS. Equities analysts expect that Align Technology, Inc. will post 7.98 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ALGN. Mizuho raised their price objective on shares of Align Technology from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Thursday. Evercore increased their target price on shares of Align Technology from $180.00 to $200.00 and gave the company an “outperform” rating in a research report on Thursday. Needham & Company LLC restated a “hold” rating on shares of Align Technology in a research note on Thursday, October 30th. Wells Fargo & Company lifted their price target on shares of Align Technology from $181.00 to $200.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, Weiss Ratings upgraded Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, January 16th. Seven investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, Align Technology presently has an average rating of “Hold” and an average target price of $195.92.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.